{"schema_version":"secwatch.filing_event.v1","accession":"0001653477-23-000054","form_type":"8-K","ticker":"NGVT","cik":"0001653477","company_name":"Ingevity Corp","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:29.948860+00:00","generated_at":"2026-06-09T02:46:51.342226+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Ingevity Q3 net sales down 7% to $446M; adjusts FY EBITDA guidance to $375-390M, plans restructuring","bullets":["Net sales $446M (-7% YoY); net income $25.2M ($0.69 EPS); adjusted EPS $1.21.","Adjusted EBITDA $110.4M, margin 24.8%; operating cash flow $106.9M, free cash flow $73.4M.","Updated FY2023 adjusted EBITDA guidance to $375-$390M.","Announced closure of DeRidder, LA facility and company-wide restructuring to reposition Performance Chemicals."],"urls":{"canonical":"https://secwatch.observer/filing/0001653477-23-000054","json":"https://secwatch.observer/filing/0001653477-23-000054.json","markdown":"https://secwatch.observer/filing/0001653477-23-000054.md","text":"https://secwatch.observer/filing/0001653477-23-000054.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653477/000165347723000054/0001653477-23-000054-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653477/000165347723000054/ngvt-20231101.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T02:46:51.342226+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4e40a1507c1135e4c68eea7306ac5e853077f564","claim":"Ingevity Corp reported the three and nine months ended September 30, 2023 results: revenue $446.0 million, net income $25.2 million, EPS $0.69.","evidence_excerpt":"Ingevity reports third quarter 2023 financial results HIGHLIGHTS : (comparisons versus prior year period) • Net sales of $446.0 million, down 7%, compared to a record prior year • Net income of $25.2 million and diluted earnings per share (EPS) of $0.69","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1653477/000165347723000054/0001653477-23-000054-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three and nine months ended September 30, 2023"},{"label":"Revenue","value":"$446.0 million"},{"label":"Net income","value":"$25.2 million"},{"label":"EPS","value":"$0.69"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}